Survey							
                            
		                
		                * Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
The EPEC-O TM Education in Palliative and End-of-life Care - Oncology Project The EPEC-O Curriculum is produced by the EPECTM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation. E P E C EPEC – Oncology Education in Palliative and End-of-life Care – Oncology O Module 3f Symptoms – Constipation Constipation . . .  Straining  Hard stool  Sensation of Incomplete evacuation Anorectal obstruction  Fewer than 3 BM / week  12 weeks duration > 2 symptoms . . . Constipation Epidemiology  Impact: abdominal discomfort / pain, nausea and vomiting  Prevalence: up to 90 % among cancer patients treated with opioids  Prognosis: can limit prognosis if untreated Management always possible Key points 1. Pathophysiology 2. Assessment 3. Management Pathophysiology  Medications Opioids Calcium-channel blockers Anticholinergic    Decreased motility Ileus Mechanical obstruction      Metabolic abnormalities Spinal cord compression Dehydration Autonomic dysfunction Malignancy Assessment  Specifically ask about bowel function  Establish what is normal for patient Management  General measures  Specific measures Regular toileting Softeners Gastrocolic reflex Osmotics Activity Stimulants Lubricants Large volume enemas Stool softeners (detergent laxatives)  Sodium docusate  Calcium docusate  Phospho-soda enema PRN Stimulant laxatives  Prune juice  Senna  Casanthranol  Bisacodyl Osmotic laxatives  Lactulose or sorbitol  Milk of magnesia (other Mg salts)  Magnesium citrate  Polyethylene glycol Lederle FA, et al. Am J Med, 1990. Attar A, et al. Gut, 1999. Lubricants / enemas  Glycerin suppositories  Phosphate enema  Oil retention enema  Tap water, 500 – 1,000 ml Constipation from opioids . . .  Occurs with all opioids  Pharmacological tolerance develops slowly, or not at all  Dietary interventions alone usually not sufficient  Avoid bulk-forming agents in debilitated patients Bagnol D, et al. Neuroscience, 1997. . . . Constipation from opioids  Combination stimulant / softeners are useful first-line medications Casanthranol + docusate sodium Senna + docusate sodium  Prokinetic agents  Opioid antagonists Sykes NP. Palliat Med, 2000. E P E C Summary O Use comprehensive assessment and pathophysiology-based therapy to treat the cause and improve the cancer experience